Subscribe to RSS
DOI: 10.1055/a-0586-3974
Katarakt bei Uveitis
Cataracts in UveitisPublication History
eingereicht 11 January 2018
akzeptiert 26 February 2018
Publication Date:
08 May 2018 (online)
Zusammenfassung
Eine häufige Komplikation bei Uveitis ist die Katarakt, deren Management anspruchsvoll sein kann. Die Operationsplanung setzt eine Kenntnis von Ursache (z. B. infektiös versus nichtinfektiös) und Verlauf der Uveitis voraus, einschließlich aller intraokularen Komorbiditäten (z. B. Makulaödem). Die präoperative Patientenselektion ist bei Uveitispatienten zum Erzielen guter Operationsergebnisse bei Uveitis besonders bedeutsam. Mit steroidsparenden krankheitsmodifizierenden antirheumatischen Medikamenten (DMARDs) kann die Rate postoperativer Komplikationen reduziert und das Visusergebnis verbessert werden. Vor der Operation muss eine stabile Entzündungskontrolle erzielt werden. Die Operation sollte minimalinvasiv erfolgen. Eine IOL-Implantation sollte nicht bei Patienten mit unvorhersehbarem Entzündungsverlauf erfolgen. Durch die Verwendung von intraokularen Kortikosteroiden (z. B. Dexamethason-Azetonid-Implantat, Triamcinolon-Azetonid) kann die Komplikationsrate reduziert werden. Postoperativ sollte die entzündungshemmende Medikation intensiviert und diese bis zu 3 Monate lang fortgesetzt werden. Bei sorgsamer Patientenauswahl, Planung und Durchführung der Kataraktoperation sowie postoperativer Nachsorge können bei Uveitispatienten zufriedenstellende anatomische und visuelle Operationsergebnisse erzielt werden.
Abstract
Cataracts are a frequent complication of uveitis, and their management can be challenging. Operation planning requires knowledge of the cause (e.g., infectious versus noninfectious) and course of uveitis, including any intraocular comorbidities (e.g., macular edema). Preoperative patient selection is particularly important in uveitis patients to achieve good surgical results. Steroid-sparing disease-modifying antirheumatic drugs (DMARDs) can reduce the rate of postoperative complications and can improve visual acuity. Before the operation, a stable inactivity of intraocular inflammation must be achieved. The surgical approach should be minimally invasive. Intraocular lens implantation should only be performed under stable inflammatory control. By using intraocular corticosteroids (e.g., dexamethasone acetonide implant, triamcinolone acetonide) the complication rate can be reduced. Postoperatively, the additional anti-inflammatory medication should be intensified and continued for up to 3 months. With careful patient selection, planning and execution of cataract surgery and postoperative care, satisfactory anatomical and functional outcomes can be achieved in uveitis patients.
-
Literatur
- 1 Hooper PL, Rao NA, Smith RE. Cataract extraction in uveitis patients. Surv Ophthalmol 1990; 35: 120-144
- 2 Thorne JE, Woreta FA, Dunn JP. et al. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology 2010; 117: 1436-1441
- 3 Grajewski RS, Zurek-Imhoff B, Roesel M. et al. Favourable outcome after cataract surgery with IOL implantation in uveitis associated with juvenile idiopathic arthritis. Acta Ophthalmol 2012; 90: 657-662
- 4 Heiligenhaus A, Niewerth M, Ganser G. et al. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 2007; 46: 1015-1019
- 5 Kotaniemi K, Kautiainen H, Karma A. et al. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology 2001; 108: 2071-2075
- 6 Dick AD, Tundia N, Sorg R. et al. Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Ophthalmology 2016; 123: 655-662
- 7 Thorne JE, Skup M, Tundia N. et al. Direct and indirect resource use, healthcare costs and work force absence in patients with non-infectious intermediate, posterior or panuveitis. Acta Ophthalmol 2016; 94: e331-e339
- 8 Sijssens KM, Rothova A, Van De Vijver DA. et al. Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 2007; 144: 574-579
- 9 Behndig A, Cochener-Lamard B, Guell J. et al. Surgical, antiseptic, and antibiotic practice in cataract surgery: Results from the European Observatory in 2013. J Cataract Refract Surg 2015; 41: 2635-2643
- 10 Mondino BJ, Rajacich GM, Sumner H. Comparison of complement activation by silicone intraocular lenses and polymethylmethacrylate intraocular lenses with polypropylene loops. Arch Ophthalmol 1987; 105: 989-990
- 11 Abela-Formanek C, Amon M, Kahraman G. et al. Biocompatibility of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses in eyes with uveitis having cataract surgery: Long-term follow-up. J Cataract Refract Surg 2011; 37: 104-112
- 12 Alió JL, Chipont E, BenEzra D. et al. Comparative performance of intraocular lenses in eyes with cataract and uveitis. J Cataract Refract Surg 2002; 28: 2096-2108
- 13 Papaliodis GN, Nguyen QD, Samson CM. et al. Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Semin Ophthalmol 2002; 17: 120-123
- 14 Roesel M, Heinz C, Heimes B. et al. Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis – a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1609-1615
- 15 Abela-Formanek C, Amon M, Schauersberger J. et al. Results of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses in uveitic eyes with cataract: comparison to a control group. J Cataract Refract Surg 2002; 28: 1141-1152
- 16 Leung TG, Lindsley K, Kuo IC. Types of intraocular lenses for cataract surgery in eyes with uveitis. Cochrane Database Syst Rev 2014; (03) CD007284 DOI: 10.1002/14651858.CD007284.pub2.
- 17 Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140: 509-516
- 18 Tejwani S, Murthy S, Sangwan VS. Cataract extraction outcomes in patients with Fuchsʼ heterochromic cyclitis. J Cataract Refract Surg 2006; 32: 1678-1682
- 19 Bosch-Driessen LH, Plaisier MB, Stilma JS. et al. Reactivations of ocular toxoplasmosis after cataract extraction. Ophthalmology 2002; 109: 41-45
- 20 Nemet AY, Raz J, Sachs D. et al. Primary intraocular lens implantation in pediatric uveitis: a comparison of 2 populations. Arch Ophthalmol 2007; 125: 354-360
- 21 Miranda M, Alió JL. Selection of surgical Technique for complicated Cataract in Uveitis. In: Becker MD, Davis JL. eds. Surgical Management of inflammatory Eye Disease. Berlin, Heidelberg: Springer; 2008
- 22 Mora P, Gonzales S, Ghirardini S. et al. Perioperative prophylaxis to prevent recurrence following cataract surgery in uveitic patients: a two-centre, prospective, randomized trial. Acta Ophthalmol 2016; 94: e390-e394
- 23 Mehta S, Linton MM, Kempen JH. Outcomes of cataract surgery in patients with uveitis: a systematic review and meta-analysis. Am J Ophthalmol 2014; 158: 676-692.e7
- 24 Sykakis E, Karim R, Parmar DN. Management of patients with herpes simplex virus eye disease having cataract surgery in the United Kingdom. J Cataract Refract Surg 2013; 39: 1254-1259
- 25 Dada T, Dhawan M, Garg S. et al. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract. J Cataract Refract Surg 2007; 33: 1613-1618
- 26 Larochelle MB, Smith J, Dacey MS. Dexamethasone intravitreal implant in the treatment of uveitic macular edema in the perioperative cataract setting: a case series. Am J Ophthalmol 2016; 166: 149-153
- 27 Foster RE, Lowder CY, Meisler DM. et al. Extracapsular cataract extraction and posterior chamber intraocular lens implantation in uveitis patients. Ophthalmology 1992; 99: 1234-1241
- 28 Kotaniemi K, Penttila H. Intraocular lens implantation in patients with juvenile idiopathic arthritis-associated uveitis. Ophthalmic Res 2006; 38: 318-323
- 29 Androudi S, Letko E, Meniconi M. et al. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema. Ocul Immunol Inflamm 2005; 13: 205-212
- 30 Grzybowski A, Kanclerz P, Pleyer U. Challenges with cataract surgery in pars planitis patients. Graefes Arch Clin Exp Ophthalmol 2017; 255: 1483-1484
- 31 Haberle H, Velhagen KH, Pleyer U. [Pseudophakia in children with juvenile arthritis]. Ophthalmologe 1998; 95: 823-827
- 32 Adan A, Gris O, Pelegrin L. et al. Explantation of intraocular lenses in children with juvenile idiopathic arthritis-associated uveitis. J Cataract Refract Surg 2009; 35: 603-605
- 33 Zhang L, Hood CT, Vrabec JP. et al. Mechanisms for in-the-bag uveitis-glaucoma-hyphema syndrome. J Cataract Refract Surg 2014; 40: 490-492
- 34 Sen HN, Abreu FM, Louis TA. et al. Cataract surgery outcomes in uveitis: The Multicenter Uveitis Steroid Treatment Trial. Ophthalmology 2016; 123: 183-190
- 35 Brady CJ, Villanti AC, Law HA. et al. Corticosteroid implants for chronic non-infectious uveitis. Cochrane Database Syst Rev 2016; (02) CD010469
- 36 Kiew S, Forrester JV, Chee SP. et al. Intravenous ‘pulse’ methylprednisolone for the treatment of inflammatory cystoid macular oedema. Br J Ophthalmol 2012; 96: 1531-1533
- 37 Pleyer U, Ursell PG, Rama P. Intraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?. Ophthalmol Ther 2013; 2: 55-72
- 38 Ganesh SK, Babu K, Biswas J. Phacoemulsification with intraocular lens implantation in cases of pars planitis. J Cataract Refract Surg 2004; 30: 2072-2076
- 39 Rahman I, Jones NP. Long-term results of cataract extraction with intraocular lens implantation in patients with uveitis. Eye (Lond) 2005; 19: 191-197
- 40 Belair ML, Kim SJ, Thorne JE. et al. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol 2009; 148: 128-135.e2
- 41 Chieh JJ, Carlson AN, Jaffe GJ. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis. Am J Ophthalmol 2008; 146: 589-594
- 42 Williams GA, Haller JA, Kuppermann BD. et al. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol 2009; 147: 1048-1054 1054.e1–2
- 43 Cervantes-Castaneda RA, Giuliari GP, Gallagher MJ. et al. Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up. Eur J Ophthalmol 2009; 19: 622-629
- 44 Bae JH, Lee CS, Lee SC. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Retina 2011; 31: 111-118
- 45 Soheilian M, Rabbanikhah Z, Ramezani A. et al. Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study. J Ocul Pharmacol Ther 2010; 26: 199-206
- 46 Liu X, Zhao C, Xu T. et al. Visual prognosis and associated factors of phacoemulsification and intraocular lens implantation in different uveitis entities in Han Chinese. Ocul Immunol Inflamm 2017; 25: 349-355
- 47 Kosker M, Sungur G, Celik T. et al. Phacoemulsification with intraocular lens implantation in patients with anterior uveitis. J Cataract Refract Surg 2013; 39: 1002-1007
- 48 Hu K, Lei B, Kijlstra A. et al. Male sex, erythema nodosum, and electroretinography as predictors of visual prognosis after cataract surgery in patients with Behcet disease. J Cataract Refract Surg 2012; 38: 1382-1388
- 49 Pleyer U, Pawlikowska J, Zierhut M. et al. [Clinical aspects, follow-up and results of cataract extraction in uveitis]. Ophthalmologe 1992; 89: 295-300
- 50 Chu CJ, Dick AD, Johnston RL. et al. Cataract surgery in uveitis: a multicentre database study. Br J Ophthalmol 2017; 101: 1132-1137